Characterization of ABT-806, a Humanized Tumor-Specific Anti-EGFR Monoclonal Antibody

Molecular Cancer Therapeutics
Edward B ReillyAndrew M Scott

Abstract

Despite clinical efficacy, current approved agents targeting EGFR are associated with on-target toxicities as a consequence of disrupting normal EGFR function. MAb 806 is a novel EGFR antibody that selectively targets a tumor-selective epitope suggesting that a mAb 806-based therapeutic would retain antitumor activity without the on-target toxicities associated with EGFR inhibition. To enable clinical development, a humanized variant of mAb 806 designated ABT-806 was generated and is currently in phase 1 trials. We describe the characterization of binding and functional properties of ABT-806 compared with the clinically validated anti-EGFR antibody cetuximab. ABT-806 binds the mutant EGFRvIII with high affinity and, relative to cetuximab, exhibits increased potency against glioblastoma multiforme cell line and patient-derived xenografts expressing this form of the receptor. ABT-806 also inhibits the growth of squamous cell carcinoma xenograft models expressing high levels of wild-type EGFR, associated with inhibition of EGFR signaling, although higher doses of ABT-806 than cetuximab are required for similar activity. ABT-806 enhances in vivo potency of standard-of-care therapies used to treat glioblastoma multiforme and head an...Continue Reading

References

May 6, 1983·Science·D J HnatowichP W Doherty
Jan 8, 2003·Proceedings of the National Academy of Sciences of the United States of America·Achim A JungbluthWebster K Cavanee
Nov 7, 2003·Genes, Chromosomes & Cancer·Ajay PanditaC David James
Mar 11, 2005·The New England Journal of Medicine·Roger StuppUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Aug 8, 2006·Seminars in Oncology·John Mendelsohn, Jose Baselga
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andrew M ScottLloyd J Old
Sep 19, 2008·Growth Factors·Antony W Burgess
Jan 1, 2009·Journal of the National Cancer Institute·Ken Garber
Mar 18, 2009·Proceedings of the National Academy of Sciences of the United States of America·Thomas P J GarrettTerrance G Johns
May 20, 2009·Targeted Oncology·Tianhong Li, Roman Perez-Soler
Jul 16, 2011·Journal of Neuropathology and Experimental Neurology·Matthias PreusserJohannes A Hainfellner
Apr 16, 2014·PloS One·Friederike PastoreKarsten Spiekermann

❮ Previous
Next ❯

Citations

Nov 21, 2015·Chemical Research in Toxicology·Eric Blomme, Yvonne Will
Jul 5, 2017·Nature Reviews. Clinical Oncology·Hui K GanAndrew M Scott
Mar 10, 2018·The AAPS Journal·Ingrid J G BurvenichAndrew M Scott
Jan 27, 2018·Oncotarget·Rosalin MishraJoan T Garrett
Jul 11, 2020·Zhurnal voprosy neĭrokhirurgii imeni N. N. Burdenko·A M KopylovI N Pronin
Feb 24, 2018·Neuro-oncology·Victor A Levin, Benjamin M Ellingson
Feb 25, 2020·Journal of Oncology·Adrianna RutkowskaPiotr Rieske
Jul 30, 2020·Current Treatment Options in Oncology·Nicholas P Tschernia, Simon Khagi
Aug 16, 2016·Targeted Oncology·Radoslaw KwapiszewskiKarolina Adamkiewicz
Jun 10, 2017·Frontiers in Oncology·Kristina EllwangerMartin Treder
Jan 22, 2020·Expert Opinion on Biological Therapy·David B AltshulerMaria G Castro
Jun 19, 2019·Scientific Reports·Satoshi KawanoYoshito Kishi
Oct 14, 2020·Cell Biology International·S Daisy PrecillaAnitha Thirugnanasambandhar Sivasubramanian
Feb 28, 2018·Molecular Cancer Therapeutics·Andrew C PhillipsEdward B Reilly
Feb 6, 2016·Molecular Cancer Therapeutics·Andrew C PhillipsEdward B Reilly
Aug 28, 2020·Molecular Cancer Therapeutics·Mark G AndersonEdward B Reilly
Nov 15, 2020·International Journal of Molecular Sciences·Peter C Pan, Rajiv S Magge
Jan 17, 2021·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Puey Ling ChiaThomas John
Jan 30, 2021·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hui K GanAndrew M Scott
Mar 24, 2020·Chemical Reviews·Weijun WeiWeibo Cai
Sep 4, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Jun WangSteven Hansel
Sep 27, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jessica WagnerStephen Gottschalk
Oct 23, 2021·Experimental and Therapeutic Medicine·Ani-Simona SevastreAnica Dricu
Oct 6, 2021·Neuro-oncology·Youri HoogstratePim J French

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.